Cargando…
Knockdown of CENPW Inhibits Hepatocellular Carcinoma Progression by Inactivating E2F Signaling
AIM: This study aimed to evaluate the effects of centromere protein W (CENPW, also known as CUG2) in hepatocellular carcinoma (HCC). METHODS: CENPW expression in HCC tissues and cells was detected by RT-qPCR assay. CCK-8 and colony formation assay were used to assess cell proliferation. Wound healin...
Autores principales: | Zhou, Yajing, Chai, Hua, Guo, Lei, Dai, Zhongqiu, Lai, Jianming, Duan, Jianping, Liu, Yanting, Ding, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120521/ https://www.ncbi.nlm.nih.gov/pubmed/33973496 http://dx.doi.org/10.1177/15330338211007253 |
Ejemplares similares
-
Investigating CENPW as a Novel Biomarker Correlated With the Development and Poor Prognosis of Breast Carcinoma
por: Wang, Luyang, et al.
Publicado: (2022) -
Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL-6/JAK/STAT3 pathway activation in hepatocellular carcinoma
por: Ding, Qian, et al.
Publicado: (2021) -
Rare ROS1-CENPW gene in pancreatic acinar cell carcinoma and the effect of crizotinib plus AG chemotherapy: A case report
por: Wang, Tao, et al.
Publicado: (2023) -
CMTM6 knockdown prevents glioma progression by inactivating the mTOR pathway
por: Wei, Li, et al.
Publicado: (2022) -
Knockdown of POLQ interferes the development and progression of hepatocellular carcinoma through regulating cell proliferation, apoptosis and migration
por: Pan, Qi, et al.
Publicado: (2021)